FLP/FRT and Cre/lox recombination technology in C. elegans.

E Jane Albert Hubbard1

  • 1New York University School of Medicine, Skirball Institute of Biomolecular Medicine, Department of Pathology, and Helen L. and Martin S. Kimmel Center for Stem Cell Biology, 540 First Avenue, New York, NY 10016, USA.

Summary

Researchers are advancing gene expression control in C. elegans using site-specific recombination. This powerful technology allows precise temporal and spatial regulation of gene activity, bringing researchers closer to controlling gene products and visible markers.